Synapse - Mark Kris

Results (223)

Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: Higher susceptibility of women to smoking-related KRAS-mutant cancers

Journal Article

Dogan, S.; Shen, R.; Ang, D. C.; Johnson, M. L.; D'Angelo, S. P.; Paik, P. K.; Brzostowski, E. B.; Riely, G. J.; Kris, M. G.; Zakowski, M. F.; more...
Clinical Cancer Research (2012)

Fulltext@MSK | Save

Prevalence, clinicopathologic associations, and molecular spectrum of ERBB2 (HER2) tyrosine kinase mutations in lung adenocarcinomas

Journal Article

Arcila, M. E.; Chaft, J. E.; Nafa, K.; Roy Chowdhuri, S.; Lau, C.; Zaidinski, M.; Paik, P. K.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
Clinical Cancer Research (2012)

Fulltext@MSK | Save

Lung cancers with acquired resistance to EGFR inhibitors occasionally harbor BRAF gene mutations but lack mutations in KRAS, NRAS, or MEK1

Journal Article

Ohashi, K.; Sequist, L. V.; Arcila, M. E.; Moran, T.; Chmielecki, J.; Lin, Y. L.; Pan, Y.; Wang, L.; de Stanchina, E.; Shien, K.; more...
Proceedings of the National Academy of Sciences of the United States of America (2012)

Fulltext@MSK | Save

Molecular and clinicopathologic characteristics of HER2 mutant lung adenocarcinoma (ADC)

Meeting Abstract

Chowdhuri, S. R.; Chaft, J.; Nafa, K.; Kris, M.; Zakowski, M.; Ladanyi, M.; Arcila, M.
Modern Pathology (2012)

Fulltext@MSK | Save

Molecular and clinicopathologic characteristics of HER2 mutant lung adenocarcinoma (ADC)

Meeting Abstract

Chowdhuri, S. R.; Chaft, J.; Nafa, K.; Kris, M.; Zakowski, M.; Ladanyi, M.; Arcila, M.
Laboratory Investigation (2012)

Fulltext@MSK | Save

Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: Lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations

Journal Article

Rekhtman, N.; Paik, P. K.; Arcila, M. E.; Tafe, L. J.; Oxnard, G. R.; Moreira, A. L.; Travis, W. D.; Zakowski, M. F.; Kris, M. G.; Ladanyi, M.
Clinical Cancer Research (2012)

Fulltext@MSK | Save

EGFR exon 19 insertions: A new family of sensitizing EGFR mutations in lung adenocarcinoma

Journal Article

He, M.; Capelletti, M.; Nafa, K.; Yun, C. H.; Arcila, M. E.; Miller, V. A.; Ginsberg, M. S.; Zhao, B.; Kris, M. G.; Eck, M. J.; more...
Clinical Cancer Research (2012)

Fulltext@MSK | Save

Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling

Journal Article

Chaft, J. E.; Arcila, M. E.; Paik, P. K.; Lau, C.; Riely, G. J.; Pietanza, M. C.; Zakowski, M. F.; Rusch, V.; Sima, C. S.; Ladanyi, M.; more...
Molecular Cancer Therapeutics (2012)

Fulltext@MSK | Save

Clinical, pathologic, and molecular characteristics of patients with non-small cell lung cancer harboring mutations in PIK3CA

Meeting Abstract

Pietanza, M. C.; Arcila, M. E.; Chaft, J. E.; Zakowski, M. F.; Ladanyi, M.; Riely, G. J.; Kris, M. G.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Maintained sensitivity to EGFR tyrosine kinase inhibitors (TKIs) in EGFR-mutant lung cancers that recur after adjuvant TKI

Meeting Abstract

Oxnard, G. R.; Janjigian, Y. Y.; Arcila, M. E.; Kris, M. G.; Ladanyi, M.; Azzoli, C. G.; Miller, V. A.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save